The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

Discuss ongoing/planned clinical trials in HIV transmission prevention; and. Discuss public health/health policy implications in the area of HIV transmission.

The proposed cuts have caused concerns among some Senate Republicans, including Utah Sen. John Curtis, who may consider ...

The WHO’s Director-General described the policy guidelines for Gilead’s twice-yearly drug as the “next best thing” in the ...

The global HIV-1 epidemic is primarily driven by sexual transmission. 2 Potent, durable HIV-1 prevention strategies are required to reduce the risk of viral transmission from infected persons to ...

Another critical area of HIV prevention is the prevention of mother-to-child transmission (PMTCT). Through early HIV testing during pregnancy, prompt initiation of treatment for HIV-positive ...

Timely treatment can stop the spread of HIV/AIDS in many ways. In patients, it stops the virus from progressing into AIDS, and it prevents damage to organs such as the heart, liver and kidneys, which ...

Groundbreaking twice-a-year HIV drug that could stop transmission approved. It's unclear how many people in the US and abroad will get access to the powerful new HIV prevention medication ...

To evaluate the effect of combination antiretroviral therapy on the prevention of HIV-1 transmission to uninfected partners and on clinical events in infected persons, the HIV Prevention Trials ...

Sub-Saharan Africa remains the epicenter of the AIDS pandemic. Trump's cuts have restricted the availability of drugs that ...

Role of Antiretroviral Therapy in the Prevention of HIV Transmission. Myron S. Cohen, MD, Chief of the Division of Infectious Diseases at the University of North Carolina School of Medicine at ...